Vanberra Signal

eADMET

Curated by Signal

Developer of an integrative software platform to analyze the property of the drug molecule

Overview

eADMET is involved in developing a software solution to analyze the absorption, distribution, metabolism, excretion and toxicity (ADMET) of the drug molecule. The company's flagship product includes a web-based database system, OCHEM that analyze the physical and chemical structure of the drug molecule to predict the ADME. The technology platform also provides structural information and identifies the mode of action of a drug molecule. The company's other product ePhysChem is used for the estimation of physicochemical and ADME properties. It uses contains AlogPS 3.01 for logP and logS prediction. The company also provides consulting services in the adaption and creation of drug models.

Key facts

Founded
2006
Headquarters
Garching, Germany

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of an online platform for cannabis business directory

    Health TechnologyMarktredwitz, Germany
  • Provider of an online health information platform for multiple diseases

    Health TechnologyBerlin, Germany
  • Provider of speech therapy products for disabled people

    Health TechnologyLindlar, Germany

About eADMET

What does eADMET do?

eADMET is involved in developing a software solution to analyze the absorption, distribution, metabolism, excretion and toxicity (ADMET) of the drug molecule.

Where is eADMET headquartered?

eADMET is headquartered in Garching, Germany.

When was eADMET founded?

eADMET was founded in 2006.

Which sector is eADMET in?

eADMET operates in Health Technology.

Who are eADMET's competitors?

Companies similar to eADMET include Cannabis, Vila Health, and LogoMedien.